Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleClinical Practice

Dyslipidemia Prevalence in a Laboratory Initiated Screening Program

Jane F Emerson and Mahtab Jafari
American Society for Clinical Laboratory Science April 2002, 15 (2) 67-70; DOI: https://doi.org/10.29074/ascls.15.2.67
Jane F Emerson
is Chief of Clinical Pathology at the University of California, Irvine Medical Center, Orange CA
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jemerson@uci.edu
Mahtab Jafari
is Assistant Clinical Professor, Department of Medicine, University of California, Irvine CA
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Jane F Emerson, MD PhD⇑
    1. is Chief of Clinical Pathology at the University of California, Irvine Medical Center, Orange CA
  2. Mahtab Jafari, PharmD
    1. is Assistant Clinical Professor, Department of Medicine, University of California, Irvine CA
  1. Address for correspondence: Jane F Emerson MD PhD, Chief of Clinical Pathology, Rt 38, University of California, Irvine Medical Center, 101 The City Drive, Orange CA 92868. (714) 456-7557, (714) 456-8272 (fax). jemerson{at}uci.edu

Abstract

OBJECTIVE: Evaluate utilization and diagnosis rates in a self-pay, self-referred screening program for dyslipidemia.

DESIGN: 301 patients self-referred to the clinical laboratory for lipid testing in a two-year period. The patient population that participated was characterized in terms of insurance status, gender, age, and known cardiovascular risk factors. Lipid profiles were characterized as measured by total cholesterol, triglycerides (TGs), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and total cholesterol to HDL risk factor.

SETTING: Clinical laboratory in an academic medical center.

PATIENTS: Data from all patients that self-selected for screening were included.

INTERVENTIONS: Immediate laboratory results with both verbal and written interpretations and recommendations were provided to the patients.

MAIN OUTCOME MEASURES: Age, gender, insurance status, number of known risk factors, and lipid profiles in the subject group.

RESULTS: The mean age of participants was 57 years. Men (197) outnumbered women (104) by almost 2:1; most (94%) had health insurance. At presentation, 44% of the patients had more than one risk factor for coronary heart disease (CHD). 151 individuals (50%) had lipid findings that would require at least dietary intervention by NCEP guidelines.

CONCLUSION: A self-pay, self-referred screening program for lipid disorders is an effective means of improving screening and diagnosis rates. Patients with insurance were willing to pay for the convenience offered and men in particular were more likely to self-refer than women, independent of previous knowledge of risk factors or lipid disorders.

ABBREVIATIONS: CHD = coronary heart disease; HDL = high-density lipoprotein cholesterol; LDL = low-density lipoprotein cholesterol; NCEP = National Cholesterol Education Program; RF = risk factor; TG = triglyceride.

    INDEX TERMS
  • cardiovascular
  • direct-access laboratory testing
  • dyslipidemia
  • lipids
  • risk factors
  • screening
  • © Copyright 2002 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 15 (2)
American Society for Clinical Laboratory Science
Vol. 15, Issue 2
Spring 2002
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dyslipidemia Prevalence in a Laboratory Initiated Screening Program
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dyslipidemia Prevalence in a Laboratory Initiated Screening Program
Jane F Emerson, Mahtab Jafari
American Society for Clinical Laboratory Science Apr 2002, 15 (2) 67-70; DOI: 10.29074/ascls.15.2.67

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Dyslipidemia Prevalence in a Laboratory Initiated Screening Program
Jane F Emerson, Mahtab Jafari
American Society for Clinical Laboratory Science Apr 2002, 15 (2) 67-70; DOI: 10.29074/ascls.15.2.67
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Practice

  • Utility of Immunofixation as a Follow-up to Select Abnormal Serum Protein Electrophoresis Patterns and Suggestions for Clinical Correlation
  • Public Datasets: A Foundation to Artificial Intelligence in Health Care
  • Comparison of Laboratory Scientist and CellaVision DM9600 Classification of Reactive Lymphocytes
Show more Clinical Practice

Chemistry

  • Using the Urine Dipstick to Screen Out Unnecessary Urine Cultures: Implementation at One Facility
Show more Chemistry

Similar Articles

Keywords

  • cardiovascular
  • direct-access laboratory testing
  • dyslipidemia
  • lipids
  • risk factors
  • screening

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire